McKesson Corporation $MCK Stake Cut by Moody National Bank Trust Division

Moody National Bank Trust Division lessened its holdings in McKesson Corporation (NYSE:MCK) by 30.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,344 shares of the company’s stock after selling 591 shares during the period. Moody National Bank Trust Division’s holdings in McKesson were worth $1,102,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently modified their holdings of MCK. GGM Financials LLC acquired a new position in shares of McKesson in the 3rd quarter valued at about $25,000. State of Wyoming acquired a new stake in McKesson during the second quarter worth about $29,000. Hopwood Financial Services Inc. acquired a new stake in McKesson during the third quarter worth about $31,000. Vermillion & White Wealth Management Group LLC bought a new position in McKesson in the third quarter worth about $33,000. Finally, Board of the Pension Protection Fund bought a new position in McKesson in the fourth quarter worth about $33,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Activity at McKesson

In other news, Director Maria Martinez sold 349 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total value of $328,014.63. Following the completion of the transaction, the director owned 301 shares of the company’s stock, valued at approximately $282,900.87. This represents a 53.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Michele Lau sold 2,725 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total value of $2,697,750.00. Following the transaction, the executive vice president directly owned 3,247 shares in the company, valued at $3,214,530. This trade represents a 45.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 3,868 shares of company stock worth $3,743,820 in the last ninety days. 0.08% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

MCK has been the subject of several recent research reports. Leerink Partners reaffirmed an “outperform” rating and set a $1,085.00 target price on shares of McKesson in a report on Thursday, March 5th. Evercore reissued an “outperform” rating on shares of McKesson in a report on Thursday, March 5th. Morgan Stanley restated an “overweight” rating and set a $966.00 price objective on shares of McKesson in a research report on Thursday, January 29th. TD Cowen upped their price objective on McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Finally, JPMorgan Chase & Co. increased their target price on McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Thirteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $960.93.

McKesson Trading Down 0.3%

NYSE MCK opened at $879.57 on Thursday. The company has a 50-day moving average price of $906.79 and a two-hundred day moving average price of $837.49. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00. The stock has a market cap of $107.74 billion, a price-to-earnings ratio of 25.30, a price-to-earnings-growth ratio of 1.42 and a beta of 0.38.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. During the same period in the previous year, the firm posted $8.03 earnings per share. The business’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities research analysts expect that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s payout ratio is 9.43%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.